Rogers Corporation 2023 Q3 Form 10-Q Summary
Business Context and Reporting Period
Rogers Corporation designs and manufactures engineered materials and components for advanced electronics, electrified vehicles, automotive ADAS, aerospace and defense, renewable energy, communications, industrial and other applications. Its strategic segments are Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS), with remaining non-core activities reported as Other. This unaudited Form 10-Q covers the three and nine months ended September 30, 2023, compared with the corresponding 2022 periods.
Key Financial Metrics
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|---|---|---|---|
| Net sales | $229.1 million | $247.2 million | $703.8 million | $747.5 million |
| Gross margin | $80.4 million; 35.1% | $78.1 million; 31.6% | $239.7 million; 34.1% | $250.0 million; 33.4% |
| Operating income | $27.1 million; 11.8% | $18.5 million; 7.5% | $54.8 million; 7.8% | $61.8 million; 8.3% |
| Net income | $19.0 million | $14.8 million | $33.4 million | $49.3 million |
| Diluted EPS | $1.02 | $0.78 | $1.79 | $2.60 |
| Operating cash flow | Not separately provided for the quarter | $59.5 million | $1.8 million |
Q3 net sales declined 7.3% year over year, while gross margin increased approximately 350 basis points and operating margin increased approximately 430 basis points. The nine-month sales decline was 5.8%, and the nine-month gross margin improved approximately 70 basis points.
Liquidity, Debt and Financial Position
- Cash and cash equivalents were $126.5 million at September 30, 2023, down from $235.9 million at December 31, 2022. Approximately $82.1 million was held by non-U.S. subsidiaries.
- Borrowings under the revolving credit facility were $80.0 million, down from $215.0 million at year-end. Rogers made $50.0 million of discretionary principal payments in Q3 and $135.0 million during the first nine months.
- The March 2023 Fifth Amended Credit Agreement provides a $450.0 million revolving facility and a $225.0 million expansion feature, with maturity extended to March 24, 2028. The company reported compliance with its leverage and interest-coverage covenants at September 30, 2023.
- Net cash used in investing activities was $30.3 million, including $34.5 million of capital expenditures. Net cash used in financing activities was $139.6 million, primarily reflecting debt repayments.
- Inventories declined to $157.1 million from $182.4 million at year-end, while accounts receivable increased to $185.8 million from $177.4 million.
- Shareholders’ equity was $1.21 billion at September 30, 2023, compared with $1.17 billion at December 31, 2022.
Material Changes Versus the Prior Comparable Period
- AES Q3 sales decreased 3.2% to $126.4 million, while EMS sales decreased 11.7% to $98.0 million. Declines primarily reflected weaker demand in EV/HEV, aerospace and defense, portable electronics, wireless infrastructure, general industrial and consumer markets.
- Q3 operating income increased in AES to $5.7 million from $2.3 million and in EMS to $19.9 million from $14.3 million, benefiting from lower freight, duties and tariffs, factory optimization, lower raw material costs and lower costs associated with the terminated DuPont merger.
- SG&A declined 12.5% in Q3 and 8.5% for the nine-month period, primarily due to lower compensation, professional services and amortization costs.
- Restructuring charges increased to $1.9 million in Q3 and $16.4 million for the first nine months, versus $0.4 million and $1.1 million, respectively, in the prior-year periods. Charges related to workforce reductions and facility consolidations were substantially completed by September 30.
- The effective tax rate rose to 27.3% in Q3 from 16.0% and to 30.0% for nine months from 20.5%, primarily because a 2022 reduction in uncertain tax-position reserves did not recur.
- Foreign currency translation produced a $17.9 million Q3 loss in other comprehensive income, compared with a $35.0 million loss in Q3 2022.
- UTIS fire-related insurance recoveries contributed $0.7 million of other operating income in Q3 and $7.4 million for the first nine months. Commercial production at the replacement South Korea facility began in January 2023.
Guidance, Outlook, Commentary and Risks
Management expects 2023 capital expenditures of approximately $55 million to $65 million, funded through operating cash flow, cash on hand and, if necessary, the revolving facility. Management stated that available liquidity and expected operating cash flows should fund operations, planned capital expenditures, research and development and debt service for at least the next 12 months.
Management is pursuing cost reductions through manufacturing-footprint optimization, facility consolidations, workforce reductions and divestiture of non-core activities. It expects these actions to reduce manufacturing and operating costs and believes longer-term growth opportunities are strongest in EV/HEV, ADAS, aerospace and defense, portable electronics and renewable energy. No formal revenue or earnings guidance was provided in the filing.
- Key risks include demand volatility, weaker end markets, customer adoption of new technologies, global competition, raw-material and sole-source supplier availability, foreign-exchange movements, tariffs and U.S.-China trade restrictions.
- Additional risks include geopolitical and supply-chain disruptions, sanctions and export controls, cybersecurity incidents, environmental obligations, tax-rate changes, covenant compliance and the ability to execute the restructuring and growth strategy.
- Asbestos-related liabilities were $64.7 million and related insurance receivables were $59.8 million. There were 561 outstanding asbestos claims at September 30, 2023; 12 claims were settled for approximately $4.5 million during the first nine months.
- The company recorded a $0.7 million accrual for future remediation at its Connecticut facility. Management stated that known litigation and environmental matters are not expected to have a material adverse effect, but asbestos insurance coverage, claims activity and ultimate costs remain uncertain.
- The previously disclosed DuPont merger was terminated in November 2022 after regulatory approval was not obtained. Rogers received a $162.5 million termination fee before taxes and incurred a $20.4 million transaction-related fee.
Important Facts for Investors to Verify
- Whether revenue weakness in EMS and AES markets stabilizes and whether EV/HEV, ADAS, aerospace and defense and renewable-energy design wins convert into sustained sales growth.
- Whether factory optimization, workforce reductions and facility consolidations produce the expected recurring margin benefits after restructuring costs end.
- Cash generation relative to planned 2023 capital expenditures of $55 million to $65 million and the pace of additional debt repayment.
- Future interest expense and covenant headroom under the revolving credit facility, particularly if operating results weaken or interest rates remain elevated.
- The effective tax rate and potential effects of the $8.9 million of unrecognized tax benefits.
- Actual asbestos claims, settlement costs, insurance recoveries and the availability and solvency of applicable insurers.
- Completion and financial impact of the remaining asset-sale and facility-consolidation activities, including the Price Road facility that remained held for sale after the related sale agreement was terminated.